2026. Rapid Itch Relief with Upadacitinib vs Dupilumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: Results from the Phase 3b/4 Level Up Study. SKIN The Journal of Cutaneous Medicine. 10, 2 (Mar. 2026), s735. DOI:https://doi.org/10.25251/078a3s70.